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Abstract
Background: The polysialylated neuronal cell adhesion molecule (PSA-NCAM) is considered a marker of
developing and migrating neurons and of synaptogenesis in the immature vertebrate nervous system. However,
it persists in the mature normal brain in some regions which retain a capability for morphofunctional
reorganization throughout life. With the aim of providing information relevant to the potential for dynamic
changes of specific neuronal populations in man, this study analyses the immunohistochemical occurrence of PSA-
NCAM in the human trigeminal ganglion (TG) and brainstem neuronal populations at prenatal and adult age.
Results: Western blot analysis in human and rat hippocampus supports the specificity of the anti-PSA-NCAM
antibody and the immunodetectability of the molecule in postmortem tissue. Immunohistochemical staining for
PSA-NCAM occurs in TG and several brainstem regions during prenatal life and in adulthood. As a general rule,
it appears as a surface staining suggestive of membrane labelling on neuronal perikarya and proximal processes,
and as filamentous and dot-like elements in the neuropil. In the TG, PSA-NCAM is localized to neuronal perikarya,
nerve fibres, pericellular networks, and satellite and Schwann cells; further, cytoplasmic perikaryal staining and
positive pericellular fibre networks are detectable with higher frequency in adult than in newborn tissue. In the
adult tissue, positive neurons are mostly small- and medium-sized, and amount to about 6% of the total ganglionic
population. In the brainstem, PSA-NCAM is mainly distributed at the level of the medulla oblongata and pons and
appears scarce in the mesencephalon. Immunoreactivity also occurs in discretely localized glial structures. At all
ages examined, PSA-NCAM occurs in the spinal trigeminal nucleus, solitary nuclear complex, vestibular and
cochlear nuclei, reticular formation nuclei, and most of the precerebellar nuclei. In specimens of different age, the
distribution pattern remains fairly steady, whereas the density of immunoreactive structures and the staining
intensity may change and are usually higher in newborn than in adult specimens.
Conclusion: The results obtained show that, in man, the expression of PSA-NCAM in selective populations of
central and peripheral neurons occurs not only during prenatal life, but also in adulthood. They support the
concept of an involvement of this molecule in the structural and functional neural plasticity throughout life. In
particular, the localization of PSA-NCAM in TG primary sensory neurons likely to be involved in the transmission
of protopathic stimuli suggests the possible participation of this molecule in the processing of the relevant sensory
neurotransmission.
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Background
The polysialylated form of the cell surface glycoprotein
neural cell adhesion molecule (PSA-NCAM) is a dynami-
cally regulated product of post-translational modification
of NCAM [1,2]. Due to its large excluded volume, PSA can
produce a sufficient physical hindrance between apposing
membranes to attenuate intercellular adhesion [2,3]. The
highest expression of PSA-NCAM occurs in the developing
nervous system, where it is generally considered a pro-
moter of neural plasticity, allowing migration of neural
and nonneural precursors and facilitating axonal path-
finding and synaptogenesis [4,5]. In the normal adult
brain of experimental animals NCAM generally displays
low levels of polysialylation [6], with the exception of lim-
ited areas such as the hippocampus, the hypothalamus,
the olfactory cortex and terminal regions of primary sen-
sory afferents, which are believed to maintain a capability
for morphological reorganization throughout life [7-10].
The PSA-NCAM levels and distribution have been shown
to increase in learning and memory [11-13], chronic stress
conditions [14-16] and several lesion models such as
ischemia, epilepsy, brain trauma, and transected/crushed
peripheral nerves [2,17-22]. Interestingly, the potential of
PSA-NCAM expressing cells in promoting brain tissue
repair [23-25] and a role for this molecule in neuroprotec-
tion [26] have been pointed out.
Data regarding the occurrence of the molecule in the nor-
mal human nervous system are still limited. Studies in the
fetal brain focus on the localization of PSA-NCAM in dis-
crete forebrain regions and on its role in developmental
processes, such as neuronal migration and transitory
axonal projections [27], and onset of myelination [28]. In
the adult, evidence for the persistence of PSA-NCAM is
restricted to the cerebral cortex [29-31] and peripheral
nerve [32], where altered expression of the molecule has
also been described in a number of neuropathological
conditions [32-38]. In order to explore further the exist-
ence of neurons expressing the molecule in the human
nervous system, thus providing potential for its dynamic
changes and plasticity in response to environmental con-
tests, we analysed whether PSA-NCAM occurs in the
human primary sensory neurons, namely those of the
trigeminal ganglion (TG), and in the morphofunctional
heterogeneous populations of the brainstem. The study
has been carried out by immunohistochemistry on nor-
mal tissue and conveys data on the occurrence of PSA-
NCAM immunoreactivity in those regions at prenatal,
neonatal and adult age. It may represent a basis for future
analyses of pathological tissue specimens and, hopefully,
for prospective applications in neuronal protection and
repair. As the occurrence of PSA-NCAM and its persistence
in the adult has been already shown in the human [29]
and rat hippocampus [18,20], so as to test the antibody
specificity and gain information on the immunodetecta-
bility of the molecule in autoptic versus non autoptic tis-
sue, we also examined the detectability of PSA-NCAM in
this brain region by western blot in both newborn and
adult human and rat specimens.
Results
Western blot
In both the human and rat hippocampus tissue homoge-
nates PSA-NCAM is immunochemically detectable as a
single protein band whose level matches the expected
molecular weight [39] (Figure 1). The band is present at
all examined ages in both species. However its thickness
and staining intensity are definitely more pronounced in
the human pre- and full-term newborn versus adult tissue,
as well as in the young versus adult rat tissue. A high
degree of individual variability is also obvious among the
adult human specimens.
Immunohistochemistry
Trigeminal ganglion
PSA-NCAM is localized to neuronal perikarya, nerve fibres
in bundles and in between neurons, and satellite and
Schwann cells; further, intense cytoplasmic staining and
networks of positive pericellular fibres occur in adult tis-
sue and are detectable only occasionally in the newborn
one (Figures 2, 3).
At fetal age, a number of neuronal cell bodies appear sur-
rounded by immunoreactive material, which may be
interpreted as membrane labelling, though aspects remi-
niscent of labelled satellite cells can be found; rare neu-
rons show a cytoplasmic staining (Figure 2A).
Western blot analysis of PSA-NCAM (A) and GAPDH (B) in  human and rat hippocampal tissue homogenates Figure 1
Western blot analysis of PSA-NCAM (A) and 
GAPDH (B) in human and rat hippocampal tissue 
homogenates. wg, weeks of gestation; y, years; PD, post-
natal day.BMC Neuroscience 2008, 9:108 http://www.biomedcentral.com/1471-2202/9/108
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In adult tissue, several neurons show a peripheral immu-
noreactivity suggestive of membrane labelling (Figure
3A,B). However, a number of them seem surrounded by
immunostained satellite cells (Figure 3C,F), which makes
it difficult to unequivocally identify a membrane staining
and to ascertain a neuronal labelling. On the other hand,
a number of perikarya also show a cytoplasmic labelling,
thus allowing a morphometric analysis. This was done
considering only the cell sections where both staining of
the cytoplasmic compartment and the nucleus were
clearly detectable, such as those indicated by arrows in
Figure 3A,B. In the TG specimen from an adult subject
(case 6), they amount to about 6.4 ± 0.075% of the total
ganglionic population. Frequency histogram of those
neurons is shown in Figure 4. About 70% of the sized neu-
rons have a mean cell diameter ranging from 22 μm to 34
μm, thus falling in the class of small- and medium-sized
cells, whereas the remaining of them fall in the large size
range. Varicose fibres may be found either isolated or as
bundles of variable density (Figure 3A–C). A few non
immunolabelled neuronal cell bodies appear surrounded
by immunoreactive varicose nerve fibres (Figure 3D,E).
Brainstem
PSA-NCAM is mainly distributed at the level of the
medulla oblongata and pons and appears scarce in the
mesencephalon. The distribution pattern is uneven and
remains fairly steady in specimens of different age, though
changes in the density of immunoreactive structures and
in the staining intensity may occur in newborn compared
to adult specimens, as in the spinal trigeminal nucleus,
caudal part (see Figures 5, 6). The vast majority of PSA-
NCAM-immunolabelled structures appear as neuronal
cell bodies and processes showing mainly a peripheral
immunoreactivity suggestive of membrane labelling.
Immunoreactivity also occurs in discretely localized glial
structures, such as the dorsal median septum and the
ependymal lining (Figure 5A,C). Moreover, in the latter,
immunostained varicose thread-like elements may be
seen running across the ependyma in a basoapical direc-
tion (Figure 5C).
The trigeminal sensory nuclear complex shows an uneven
distribution of immunoreactive elements. At all ages
examined, PSA-NCAM is restricted to the spinal trigemi-
nal nucleus (Figures 5, 6, 7A), where it is represented by
neuronal cell bodies and processes, and is virtually absent
in the principal and mesencephalic nuclei. At fetal age, the
immunoreactivity labels fibres in the spinal tract of the
trigeminal nerve (Figure 5A) and in the spinal nucleus
pars caudalis, where a rich plexus and neuronal cell bod-
ies occur in the substantia gelatinosa (Figure 5A,B), and in
the pars interpolaris (Figure 7A). In adult tissue, the
immunostaining persists in the substantia gelatinosa
whereas the spinal tract and the magnocellular subnu-
cleus harbor rare elements (Figure 6A,C).
At caudal level of the medulla oblongata, besides the spi-
nal trigeminal nucleus which harbors the bulk of immu-
noreactivity, the remaining grey substance shows a very
light to moderate immunostaining in the territory of the
supraspinal, central reticular and lateral reticular nuclei.
Close to the ventral surface of the anterior funiculus, a
band of intensely immunoreactive nerve fibres can be
observed (Figure 5A). More rostrally, at the level of the
pyramidal decussation, the gracile, external cuneate and
commissural nuclei show a moderate immunolabelling in
form of loose plexuses of filamentous and dot-like ele-
ments. A moderate diffuse immunostaining is detectable
in the area postrema. Above the obex, at the level of the
inferior olive, the tegmentum shows several areas of
intense to moderate immunoreactivity encompassing
both cranial nerve and reticular formation nuclei (Figures
7, 8, 9). At all ages examined, neuronal perikarya and
PSA-NCAM in the human pre-term newborn trigeminal ganglion (case 3) Figure 2
PSA-NCAM in the human pre-term newborn trigeminal ganglion (case 3). A: immunoreactivity of perikarya as 
peripheral or cytoplasmic (arrow) labelling. B: immunoreactive nerve fibres; arrows point to immunostained Schwann cells. 
Scale bars: A, B = 50 μm.BMC Neuroscience 2008, 9:108 http://www.biomedcentral.com/1471-2202/9/108
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plexuses of labelled nerve fibres can be observed in the
solitary nuclear complex (Figures 7A, 9A,B), the vestibular
(Figures 7A, 9C,D) and cochlear nuclei (Figure 7A,B), and
the dorsal motor nucleus of the vagus nerve (Figure 7A,
9F). While its immunoreactivity is scarce in the newborn
(Figure 7A), in the adult, the hypoglossal nucleus shows a
moderate immunostaining in form of nerve fibre plexuses
surrounding non immunoreactive neuronal cell bodies
(Figure 9E). Positive fibre networks and peripherally
labelled neurons are located in the intercalatus and
prepositus hypoglossi (Figure 7A,C), the paramedian
reticular (Figure 7A), the raphe obscurus (Figure 7A, 9G),
the gigantocellular, the central reticular, the intermediate
reticular and the lateral reticular nuclei (Figure 7A). The
olivary nuclear complex shows a diffuse staining in the
neuropil at all ages (Figure 8A) with some small cell bod-
ies in adult specimens. At fetal age, the white matter sur-
rounding the inferior olive harbors isolated large,
intensely stained neurons which extend dendritic
branches towards the nucleus (Figure 8B). The arcuate
nucleus appears intensely labelled (Figure 8A). In new-
born specimens, the pyramidal tract is moderately stained
(Figure 8A). Nerve fibres, isolated or grouped in small
bundlets, occur across the medial lemniscus (Figure 8A).
In the pons, bundles of strongly immunoreactive nerve
fibres run in the eighth cranial nerve and reach the pon-
tine territory of the vestibular and cochlear nuclei, which
harbor immunoreactive cell bodies. In the newborn, at
caudalmost levels, the oral part of the dorsal paramedian
nucleus (Figure 8C) shows an intense immunoreactivity
due to positive neuronal perikarya and processes (Figure
8D). The subependymal grey contains a light punctate
labelling throughout. In the adult, a diffuse weak staining
PSA-NCAM in the human adult trigeminal ganglion (A, B: case 5, C-F: case 10) Figure 3
PSA-NCAM in the human adult trigeminal ganglion (A, B: case 5, C-F: case 10). A-C: immunostained perikarya and 
nerve fibres; in B, a tissue section immunostained for PSA-NCAM and co-stained with modified Mayer's hematoxylin is shown. 
Arrows in A and B point to PSA-NCAM immunostained neurons whose nucleus is clearly detectable. C, F: the immunolabelling 
appears localized to the satellite cells surrounding non immunoreactive neurons. D, E: pericellular varicose arborisations 
around non immunoreactive neurons. Scale bars: A-C = 50 μm; D = 25 μm; E, F = 20 μm.BMC Neuroscience 2008, 9:108 http://www.biomedcentral.com/1471-2202/9/108
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is also appreciable in the locus caeruleus neuropil in
between the unstained pigmented neurons. The caudal
pontine, gigantocellular, parvocellular, reticulotegmental,
and oral pontine reticular nuclei contain sparse neuronal
cell bodies with peripheral membrane labelling and rare
punctate and filamentous elements. The pontine nuclei
show an intense labelling due to peripherally stained neu-
ronal perikarya and a meshwork of thin filamentous and
punctate elements in between them. Labelled nerve fibres,
isolated or in bundlets, occur across the medial longitudi-
nal fasciculus, the medial lemniscus and the lateral lem-
niscus.
In the quadrigeminal plate, sparse neuronal perikarya
occur in the external and pericentral nuclei of the inferior
colliculus, the intercollicular region and the superior col-
liculus. A diffuse immunostaining, occasionally localized
to neuronal perikarya, occurs in the periacqueductal grey
and in the territory of the median and dorsal raphe nuclei.
Only in adult tissue a diffuse immunostaining can be
observed in the substantia nigra. The cerebral peduncle
harbors transversely sectioned labelled fibres. Close to the
ventral surface of the caudal mesencephalon, positive
nerve fibres form a small area of dense immunoreactivity
located along the lateral edge of the interpeduncular fossa.
Discussion
The results obtained indicate that in the human nervous
system a subpopulation of the TG primary sensory neu-
rons and several regions of the brainstem express PSA-
NCAM throughout life. Centrally, the sialylated protein
appears associated with most of the sensory nuclei, in
agreement with findings on laboratory animals and the
concept that, in these regions, the expression of growth-
related proteins may subserve structural reorganization
and synaptic plasticity in response to afferent activity
[18,40] throughout life [20]. As for the spinal trigeminal
sensory system, occurrence of the growth-associated pro-
tein-43 (GAP-43) has been reported in both the sensory
ganglion and the central nuclei [41]. The localization of
PSA-NCAM to the caudal part of the trigeminal spinal sen-
sory nucleus and its changes with age are consistent with
data on the rat dorsal horn spinal cord showing that PSA-
NCAM is more widely expressed during embryonic and
early postnatal than in adult life, when it is confined to the
superficial laminae [42,43]. Such a discrete central locali-
zation of the molecule together with the morphometric
characteristics of the immunoreactive trigeminal primary
sensory neurons point to an involvement of PSA-NCAM
in the functional roles of the elements drawn in the neu-
rotransmission and processing of protophatic sensory
stimuli. It is interesting that a PSA-dependent reversible
loss of C terminals occurs in the spinal lamina II in a
model of chronic neuropathic pain [10]. In this context, it
has been proposed that, under injury or stress conditions,
the presence of PSA allows for a local and reversible break
in the afferent pathway in response to excessive stimula-
tion and thereby could serve to protect central circuitry
from chronic sensory overload [10].
PSA-NCAM has been shown in the chicken acoustic gan-
glion cells [8], where a role for the molecule in the gan-
glion neuron plasticity and in the processing of auditory
information has been suggested. Afferents to the mouse
ventral cochlear nucleus express high levels of PSA [10]
and, similarly to the structural plasticity of nociceptive C
terminals in chronic neuropathic pain [10], it has been
reported that noxious acoustic insults are associated with
a reversible atrophy of nerve terminals in the ventral coch-
lear nucleus [44-46].
Our observations also indicate that at all ages examined
the dorsal vagal complex, namely the nucleus of the soli-
tary tract, the dorsal motor nucleus of the vagus nerve, and
the area postrema, contains PSA-NCAM-labelled neurons,
nerve fibres and terminals. A convergent set of experimen-
tal data shows that in these areas, though visceral sensori-
motor circuits are morphologically established in
newborn rats [47,48], intense dynamic changes of neuro-
nal properties still occur after birth [40,49-54]. In the rat
solitary tract nucleus, the overall PSA-NCAM expression
decreases during the first two postnatal weeks and persists
only at synapses in the adult [40]. Furthermore, PSA-
NCAM expression has been shown to be dynamically con-
trolled by the electrical stimulation of the vagal afferents
Size frequency histogram of PSA-NCAM immunoreactive  neurons in human trigeminal ganglion from an adult subject  (case 5) Figure 4
Size frequency histogram of PSA-NCAM immunore-
active neurons in human trigeminal ganglion from an 
adult subject (case 5). Cells present in 6 sections were 
measured. x-Axis values represent the mean cell diameters 
expressed in μm; y-axis reports values of relative percent fre-
quency. Curve superimposed on the histogram represent the 
theoretical normal distribution.BMC Neuroscience 2008, 9:108 http://www.biomedcentral.com/1471-2202/9/108
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[40] and, conversely, a repetitive stimulation of afferent
fibres leads to phasic and long-term plasticity in adult ani-
mals [55].
It has been shown that the rat raphe serotonin neurons do
not express PSA-NCAM [56]. Thus, it may be considered
that the staining on the raphe neuronal perikarya
observed in our specimens either belongs to those neu-
rons, marking a difference with the rat species, or reflects
the occurrence of positive elements impinging on the
raphe neuronal somata.
PSA-NCAM occurs in most of the precerebellar nuclei,
which act as a gate for the input to the cerebellum. Its
expression appears particularly robust in nuclei which
play a critical role in eye movement control, such as the
intercalatus and prepositus hypoglossi nuclei and the par-
amedian reticular nucleus [57,58].
PSA-NCAM-related neuroplasticity may also involve glial
cells. Several lines of evidence indicate that PSA-NCAM
plays a permissive role for the structural remodelling of
neuronal and glial cells, particularly in the neuroendo-
crine system, where PSA-NCAM appears to control the
retraction of the glial processes in the hypothalamo-neu-
rohypophysial system [18,59]. Moreover, changes in PSA-
NCAM in the avian ciliary ganglion after axonal injury
also involve perineuronal satellite cells [60]. In agreement
with the steric hindrance caused by the molecule [2,3], the
occurrence of PSA-NCAM in the TG may indicate sites of
detachment between the neuronal surface and its glial
ensheatment. Dynamic changes, such as remodelling of
the perikaryal surface that may be operated via other
growth-related proteins such as GAP-43 [61], may be facil-
itated by this effect. As for the finding of PSA-NCAM-pos-
itive ependymal cells in the central canal lining, it is
possible that we are observing a subpopulation of glial
cells which, as recently suggested in the human brain [62],
during gestation and up to early infancy remains undiffer-
entiated as potential neural progenitor cells.
Conclusion
The expression of PSA-NCAM in selective populations of
central and peripheral neurons indicate that the molecule
occurs both during prenatal life, suggesting a role in the
development and/or maturation of neuronal circuitry,
and in adulthood, when it may be indicative of the capac-
ity to structural and functional neuronal plasticity and is
possibly involved in the processing of sensory informa-
tion throughout life. The neurochemical characterization
PSA-NCAM in the human pre-term newborn medulla oblongata, caudal level (case 3) Figure 5
PSA-NCAM in the human pre-term newborn medulla oblongata, caudal level (case 3). A: panoramic view of the 
right half of a section at the boundary with the spinal cord. B: higher magnification of the substantia gelatinosa (sg) of the spinal 
trigeminal nucleus, caudal part (Sp5C); arrows point to labelled neuronal perikarya. C: ependymal lining of the central canal. cc; 
central canal; sp5, spinal trigeminal tract. Scale bars: A = 500 μm; B = 50 μm; C = 20 μm.BMC Neuroscience 2008, 9:108 http://www.biomedcentral.com/1471-2202/9/108
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and connectivity of the PSA-NCAM-positive neurons is an
important issue and deserves further investigation. The
localization of PSA-NCAM in primary sensory neurons
likely to be involved in the transmission of protopathic
stimuli bears a specific significance as it suggests the pos-
sible participation of this molecule in the processing of
the relevant sensory neurotransmission.
Methods
Specimens of trigeminal ganglion, brainstem segments,
and hippocampus were obtained at autopsy from subjects
of different ages, with no history of neuropathology
(Table 1). The sampling and handling of human speci-
mens conformed to the local Ethics Committee of the
National Health System in compliance with the principles
enunciated in the Declaration of Helsinki. The hippocam-
pus of male Sprague-Dawley rats sacrificed by decapita-
tion at post-natal day (PD) 1 (2 rats), PD7 (2 rats) and
adult age (2 rats) was also sampled for western blot anal-
ysis and stored at -80°C until required.
Western blot
Tissue blocks of hippocampus from a pre-term newborn
(case 1), a full-term newborn (case 5) and five adult sub-
jects (cases 6, 7, 8, 11, 12) were collected and stored at -
80°C until required. Human and rat tissue homogenates
were prepared in 50 mM Tris HCl, pH 7,5, centrifuged at
10,000 × g for 20 min, resuspended in 3 ml of Tris HCl,
pH 7,5. Protein concentrations were determined using the
Lowry method of protein assay [63] with bovine serum
albumin as standard. Proteins for each tissue homogenate
(30 μg) diluted 1:1 in loading buffer were heated to 95°C
for 3 min and separated by SDS-polyacrilamide gel elec-
trophoresis (SDS-PAGE) using 8.5% (w/v) polyacrilamide
resolving gel. Internal molecular weight standards (Kalei-
doscope Prestained Standards, Bio-Rad, Hercules, CA,
USA) were run in parallel. Two gels at a time were run for
Coomassie staining and immunoblotting, respectively.
Proteins for immunoblotting were electrophoretically
transferred on a polyvinylidene fluoride membrane (Bio-
rad) using the Mini Trans Blot Cell (Biorad). Blots were
blocked by immersion in 20 mM Tris base and 137 mM
sodium chloride (TBS) containing 5% milk powder and
0.1% Tween 20 (TBS-T), for 60 min at room temperature
and incubated overnight at 4°C with the primary anti-
body. A mouse monoclonal antibody against PSA-NCAM
(Chemicon, USA), diluted 1:5,000 in TBS containing 5%
milk powder and 0.4% Micro-O-Protect (MOP) (Boe-
hringer Mannheim), was used as primary antiserum. After
TBS-T rinse, blots were incubated for 60 min, at room
temperature, with a peroxidase-conjugated anti-mouse
serum (Chemicon), diluted 1:10,000 in TBS/T. Loading
PSA-NCAM in the human adult medulla oblongata, caudal level (case 10) Figure 6
PSA-NCAM in the human adult medulla oblongata, caudal level (case 10). A: panoramic view of the right side spinal 
trigeminal nucleus, caudal part (Sp5C), at the boundary with the spinal cord. B: control immunostaining on a section semicon-
secutive to that in A. C: higher magnification of the area framed in A; arrow points to a labelled neuron in the spinal nucleus 
substantia gelatinosa (sg). sp5, spinal trigeminal tract; fc, fasciculus cuneatus. Scale bars: A, B = 500 μm; D = 100 μm.BMC Neuroscience 2008, 9:108 http://www.biomedcentral.com/1471-2202/9/108
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PSA-NCAM in the human pre-term newborn medulla oblongata, rostral level (case 3) Figure 7
PSA-NCAM in the human pre-term newborn medulla oblongata, rostral level (case 3). A: panoramic view of the 
left side dorsal quadrant at the level of the rostral hypoglossal nucleus cell column. B: dorsal cochlear nucleus; arrows point to 
labelled neurons. C: low-power view of the dorsomedial field of the medulla oblongata at the level of the nucleus prepositus 
hypoglossi (PrH). Co, dorsal cochlear nucleus; Gi, gigantocellular nucleus; icp, inferior cerebellar peduncle; IPo, interpositus 
hypoglossi nucleus; IR, intermediate reticular nucleus; LR, lateral reticular nucleus; mlf, medial longitudinal fasciculus; mlf, 
medial longitudinal fasciculus; MVe, medial vestibular nucleus; PM, paramedian reticular nucleus; PrH, prepositus hypoglossi 
nucleus; RO, raphe obscurus nucleus; Sol, solitary nucleus; sol, solitary tract; sp5, spinal trigeminal tract; Sp5I, spinal trigeminal 
nucleus, interpolar part; IV, fourth ventricle; X, dorsal motor nucleus of the vagus nerve; XII, hypoglossal nucleus. Scale bars: A, 
C = 500 μm; B = 100 μm.BMC Neuroscience 2008, 9:108 http://www.biomedcentral.com/1471-2202/9/108
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controls were obtained by stripping and immunostaining
the membranes as above, using a monoclonal mouse anti-
body against glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (Chemicon), diluted 1:600, as primary antise-
rum, and a peroxidase-conjugated goat anti-mouse serum
(Chemicon), diluted 1:10,000, as secondary antiserum. In
order to control for non specific staining, blots were
stripped and incubated with the relevant secondary
antiserum. After TBS-T rinse, protein bands were visual-
ized on a film (Kodak X-Omat LS, Kodak, Rochester, NY)
using the ECL method (Amersham Corp.).
Immunohistochemistry
Human TG and brainstem specimens were fixed by
immersion in 4% freshly prepared phosphate-buffered
formaldehyde, pH 7.3, for 4–6 hours at 4°C, and rinsed
overnight in 0.1 M phosphate buffer (PB), pH 7.3, con-
taining 10% or 30% sucrose for adult and newborn spec-
PSA-NCAM in the human pre-term newborn rostral medulla oblongata (A-B) and caudal pons (C-E) (case 3) Figure 8
PSA-NCAM in the human pre-term newborn rostral medulla oblongata (A-B) and caudal pons (C-E) (case 3). 
A: left side ventral quadrant showing immunolabelling in the lateral reticular nucleus (LR), inferior olive (IO), pyramidal tract 
(py), and arcuate nucleus (Ar). B: a positive neuron in the white matter around the inferior olive, which extends long labelled 
processes towards the nucleus. C: low-power view of the dorsomedial field of the medulla oblongata including the dorsal par-
amedian nucleus, oral part (ODPM). D: higher magnification of the right side dorsal paramedian nucleus, oral part; arrows point 
to positive neuronal perikarya. E: modified Mayer's hematoxylin counterstaining of a tissue section semiconsecutive to that 
shown in C and adjacent to that shown in D; small arrows outline the cytoarchitectonic boundaries of the immunoreactive 
area shown in D. DPGi, dorsal paragigantocellular nucleus; ml, medial lemniscus; RM, raphe magnus nucleus. Scale bars: A, C, E 
= 500 μm; B = 20 μm; D = 50 μm.BMC Neuroscience 2008, 9:108 http://www.biomedcentral.com/1471-2202/9/108
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PSA-NCAM in the human adult medulla oblongata (case 5) Figure 9
PSA-NCAM in the human adult medulla oblongata (case 5). A, B: left side solitary nucleus (Sol) and tract (sol). C: left 
side inferior (IVe) and medial vestibular (MVe) nuclei. D: a neuronal perikaryon with membrane labelling (arrow) and fibres in 
the neuropil of the medial vestibular nucleus. E: hypoglossal nucleus. F: dorsal motor nucleus of the vagus nerve. G: perikarya 
with membrane labelling (arrows) and fibre networks in the raphe obscurus nucleus. Scale bars: A, C, E = 500 μm; B = 100 μm; 
D = 20 μm; F, G = 50 μm.BMC Neuroscience 2008, 9:108 http://www.biomedcentral.com/1471-2202/9/108
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imens, respectively. Cryostat sections 14 μm thick were
collected on chrome alum-gelatin coated slides and proc-
essed by the avidin-biotin-peroxidase complex (ABC)
immunohistochemical technique. The same anti-PSA-
NCAM antibody used for the Western blot analysis,
diluted 1:400, was applied. Biotin-conjugated goat anti-
mouse serum (Vector), diluted 1:300, was used as second-
ary antiserum. The reaction product was revealed with
ABC (BioSpa Div.), diluted 1:250, followed by incubation
with a solution of 0.1 M PB, pH 7.3, containing 0.05% 3-
3'-diaminobenzidine (Sigma), 0.04% nickel ammonium
sulphate, and 0.01% hydrogen peroxide. Incubations
with primary antiserum were carried out overnight at 4°C.
Incubations with secondary antiserum and ABC lasted 70
and 30 minutes, respectively, and were performed at
room temperature. All antisera and the ABC were diluted
in phosphate buffered saline containing 0.2% Triton X-
100 (PBS/T). Control immunostainings were obtained
either by omitting the primary antibody or by substituting
it with normal goat serum. Alternate sections were stained
with modified Mayer's hematoxylin and examined with
reference to brainstem maps in Nieuwenhuys et al. [64]
and Paxinos et al. [65] for the territorial identification.
Slides were dehydrated, cover-slipped, and observed with
an Olympus BX61 microscope. Digital images were cap-
tured with a ColorViewII Olympus telecamera.
Morphometry
Morphometric analysis was performed on TG neuronal
cell profiles of digital images captured with a 20× objec-
tive magnification. Tissue sections distant from each other
at least 84 μm and only cells in them that obviously
showed the nuclear profile were considered. Neuronal
mean diameters were automatically evaluated by Image-
ProPlus software. Statistical parameters (mean, median,
S.D.) and histograms were obtained by Statistica 6 soft-
ware. The percentage of positive perikarya was calculated
by the ratio of the total number of labelled cells found in
three to six sections to the total number of cells found in
the same sections after a modified Mayer's hematoxylin
counterstaining.
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